On ECHEMI
Home > Drugs > Jiangsu Pingguang Pharmaceutical (Jiaozuo) Co., Ltd.
Jiangsu Pingguang Pharmaceutical (Jiaozuo) Co., Ltd.
  • Founded in:

    1998-03-11
  • Country:

    China China
  • Address:

    Shenzhou Road, Jiaozuo City Urban-Rural Integration Demonstration Zone
  • Tax NO.:

    91410800173475469M
  • Registered Funds:

    11.065 million yuan
  • Email:

Related Drugs
Compound Paracetamol and Amantadine Capsules
This product is a compound preparation, each tablet contains 250 mg of acetaminophen, 100 mg of amantadine hydrochloride, 2 mg of chlorpheniramine maleate, 10 mg of artificial bezoar, and 15 mg of caffeine. The auxiliary material is starch.
Name Description Content CAS NO. Registered Holders
Acetaminophen

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

250mg 103-90-2 68
1-Adamantanamine hydrochloride

Can resist subtype I influenza virus and inhibit virus reproduction

More

Can resist subtype I influenza virus and inhibit virus reproduction

100mg 665-66-7 13
Chlorphenamine maleate

It is an anti-allergic drug that can relieve symptoms such as runny nose, nasal congestion, and sneezing.

More

It is an anti-allergic drug that can relieve symptoms such as runny nose, nasal congestion, and sneezing.

2mg 113-92-8 28
Atificial Cow-bezoar

It has antipyretic and sedative effects

More

It has antipyretic and sedative effects

10mg 1002-00-2 2
Caffeine

It is a central nervous system stimulant that can enhance the antipyretic and analgesic effects of acetaminophen and reduce central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs.

More

It is a central nervous system stimulant that can enhance the antipyretic and analgesic effects of acetaminophen and reduce central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs.

15mg 0
Roxithromycin Tablets
The main ingredient of this product is roxithromycin, and its chemical name is: 9-[0-[(2-methoxyethoxy)-methyl]oxime]erythromycin.
Name Description Content CAS NO. Registered Holders
Roxithromycin

This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. Its effect on Gram-positive bacteria is slightly worse than that of erythromycin, and its effect on Legionella pneumophila is stronger than that of erythromycin. Its antimicrobial effect on Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P position), blocking the transfer RNA (t-RNA) from binding to the P position, and also blocking the transfer of the polypeptide chain from the acceptor position (A position) to the P position, thereby inhibiting bacterial protein synthesis.

More

This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. Its effect on Gram-positive bacteria is slightly worse than that of erythromycin, and its effect on Legionella pneumophila is stronger than that of erythromycin. Its antimicrobial effect on Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P position), blocking the transfer RNA (t-RNA) from binding to the P position, and also blocking the transfer of the polypeptide chain from the acceptor position (A position) to the P position, thereby inhibiting bacterial protein synthesis.

80214-83-1 28
Painkillers
This product is a compound preparation, and its components are: each tablet contains 150mg of aminopyrine, 150mg of phenacetin, 50mg of caffeine, and 15mg of phenobarbital
Name Description Content CAS NO. Registered Holders
Aminopyrine

It inhibits the synthesis and release of prostaglandins in the hypothalamus, restores the normal responsiveness of the sensory neurons in the temperature regulation center, and has an antipyretic effect; it has an analgesic effect by inhibiting the synthesis of prostaglandins, etc.; it inhibits the synthesis and release of prostaglandins in the local tissue of inflammation, stabilizes lysosomal enzymes, and affects the phagocytic function of phagocytes, thus playing an anti-inflammatory role

More

It inhibits the synthesis and release of prostaglandins in the hypothalamus, restores the normal responsiveness of the sensory neurons in the temperature regulation center, and has an antipyretic effect; it has an analgesic effect by inhibiting the synthesis of prostaglandins, etc.; it inhibits the synthesis and release of prostaglandins in the local tissue of inflammation, stabilizes lysosomal enzymes, and affects the phagocytic function of phagocytes, thus playing an anti-inflammatory role

150mg 0
Phenacetin

It inhibits the synthesis and release of prostaglandins in the hypothalamus, restores the normal responsiveness of the receptor neurons in the temperature regulation center, and has an antipyretic effect; it has an analgesic effect by inhibiting the synthesis of prostaglandins, etc.

More

It inhibits the synthesis and release of prostaglandins in the hypothalamus, restores the normal responsiveness of the receptor neurons in the temperature regulation center, and has an antipyretic effect; it has an analgesic effect by inhibiting the synthesis of prostaglandins, etc.

150mg 62-44-2 7
Caffeine

Excites the cerebral cortex, increases sensitivity to the outside world, and constricts cerebral blood vessels, enhancing the effect of the first two drugs in relieving headaches

More

Excites the cerebral cortex, increases sensitivity to the outside world, and constricts cerebral blood vessels, enhancing the effect of the first two drugs in relieving headaches

50mg 0
Phenobarbital

It has sedative, hypnotic and anticonvulsant effects, can enhance the analgesic effect of aminopyrine and phenacetin, and prevent convulsions caused by fever

More

It has sedative, hypnotic and anticonvulsant effects, can enhance the analgesic effect of aminopyrine and phenacetin, and prevent convulsions caused by fever

15mg 0
Ofloxacin Tablets
The chemical name of this product is (±)-9-fluoro-2,3-dihydro-trimethyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridinium[1,2,3-de][1,4]benzoxazine-6-carboxylic acid, and its molecular weight is 361.37.
Name Description Content CAS NO. Registered Holders
(±)-9-Fluoro-2,3-dihydro-trimethyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridinium[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli, and has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae, and Moraxella. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli, and has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae, and Moraxella. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

0
Simvastatin Tablets
The main ingredients and their chemical names are: Simvastatin, [1S-[1a, 3a, 7b (2S*, 4S*) 8ab]]-1,2., 3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthyl-2,2-dimethylbutyrate. Molecular formula: C25H38O5, molecular weight: 418.57
Name Description Content CAS NO. Registered Holders
Simvastatin

Simvastatin can reduce normal and elevated low-density lipoprotein cholesterol (LDL-C) concentrations, and works by reducing VLDL cholesterol concentrations, inducing LDL receptors, and increasing LDL-C catabolism. At the same time, simvastatin can reduce apolipoprotein B (apoB) levels, increase high-density lipoprotein cholesterol (HDL-C) concentrations, reduce plasma triglycerides (TG), and lead to a decrease in total cholesterol/HDL-C and LDL-C/HDL-C. In addition, simvastatin has shown a preventive effect on atherosclerosis in animal experiments, pathological and clinical studies, and epidemiological studies have shown that it helps reduce the risk of coronary heart disease.

More

Simvastatin can reduce normal and elevated low-density lipoprotein cholesterol (LDL-C) concentrations, and works by reducing VLDL cholesterol concentrations, inducing LDL receptors, and increasing LDL-C catabolism. At the same time, simvastatin can reduce apolipoprotein B (apoB) levels, increase high-density lipoprotein cholesterol (HDL-C) concentrations, reduce plasma triglycerides (TG), and lead to a decrease in total cholesterol/HDL-C and LDL-C/HDL-C. In addition, simvastatin has shown a preventive effect on atherosclerosis in animal experiments, pathological and clinical studies, and epidemiological studies have shown that it helps reduce the risk of coronary heart disease.

79902-63-9 63
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.